Hadassah

Hadassah Dedicates New Lab to Defeat Zika Virus

Monday, Apr 4 2016

The Zika virus.

Prof. Dana Wolf, head of the Clinical Virology Unit in the Dept. of Clinical Microbiology and Infectious Diseases at the Hadassah Medical Center, is a world-renowned specialist in viruses and the damage they can cause to unborn babies. Responding to global anxiety about the Zika virus, Prof. Wolf and her staff recently opened a new laboratory dedicated to defeating it. The Zika virus, she says, “is dangerous in the interface between mother and unborn child.”

According to Prof. Wolf, Zika, like Rubella, can cause a variety of serious birth defects. Rubella, however, once a threatening virus that plagued the Western world, has now been taken care of through vaccination. The two viruses differ, though, in that unlike Rubella, Zika is transmitted by mosquitoes, like the Dengue virus. Dengue, however, though in the same family as Zika, is not associated with birth defects. 

Hadassah, under the direction of Prof. Benjamin Reubinoff, head of its Human Embryonic Stem Cell Research Center, has been conducting research on a more dangerous virus called cytomegalovirus (CVM), which remains in our bodies forever. Hadassah research has revealed the attack pattern of the virus, which strikes the fetus just as nerve cells are being developed. Prof. Wolf and her staff will apply the tools to Zika that were developed by Hadassah to study CMV. "We have had so many requests for help that we decided to work on this," said Prof. Wolf, who reports that Hadassah received the virus for research from the United States Centers for Disease Control and Prevention.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More